Glax­o­SmithK­line R&D re­or­ga­ni­za­tion trig­gers lay­offs at Steve­nage -- and Up­per Prov­i­dence

GSK’s new R&D chief Hal Bar­ron has made no se­cret of the fact that he has a keen in­ter­est in re­fo­cus­ing the R&D group at the phar­ma gi­ant. And that’s start­ing to play out with some lay­offs in its big R&D cen­ter at GSK’s Steve­nage cam­pus as well as its sec­ond big hub near Philadel­phia.

The phar­ma gi­ant put out a state­ment ear­li­er to­day not­ing that a “small num­ber” of roles would be af­fect­ed by the lay­offs in Steve­nage. Their state­ment:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.